{"id":"https://openalex.org/W4405048824","doi":"https://doi.org/10.1182/blood-2024-199246","title":"Outcome of Splenectomy in JAK2 Inhibitor Treated Patients with Myelofibrosis: A Mayo Clinic Experience in 34 Consecutive Cases","display_name":"Outcome of Splenectomy in JAK2 Inhibitor Treated Patients with Myelofibrosis: A Mayo Clinic Experience in 34 Consecutive Cases","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405048824","doi":"https://doi.org/10.1182/blood-2024-199246"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-199246","doi":"https://doi.org/10.1182/blood-2024-199246","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-199246","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115009429","display_name":"Patricia M. Carey","orcid":"https://orcid.org/0000-0002-9204-913X","observed_orcids":["https://orcid.org/0000-0002-9204-913X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Carey","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024612499","display_name":"Animesh Dev Pardanani","orcid":"https://orcid.org/0000-0002-9084-4148","observed_orcids":["https://orcid.org/0000-0002-9084-4148"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Animesh D. Pardanani","raw_affiliation_strings":["2Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005513529","display_name":"Patrick P. Starlinger","orcid":"https://orcid.org/0000-0002-4666-5337","observed_orcids":["https://orcid.org/0000-0002-4666-5337"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Starlinger","raw_affiliation_strings":["3Department of Surgery, Mayo Clinic, Rochester"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Surgery, Mayo Clinic, Rochester","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayalew Tefferi","raw_affiliation_strings":["4Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002643270","display_name":"Naseema Gangat","orcid":"https://orcid.org/0000-0002-9104-6172","observed_orcids":["https://orcid.org/0000-0002-9104-6172"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naseema Gangat","raw_affiliation_strings":["5Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"6662","last_page":"6662"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.8960000276565552},{"id":"https://openalex.org/keywords/splenectomy","display_name":"splenectomy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9449999928474426},{"id":"https://openalex.org/keywords/spleen-volume-reduction","display_name":"spleen volume reduction","score":0.6259999871253967},{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.6539999842643738},{"id":"https://openalex.org/keywords/srsf2-mutation","display_name":"SRSF2 mutation","score":0.972000002861023},{"id":"https://openalex.org/keywords/calr-mutation","display_name":"CALR mutation","score":0.5529999732971191},{"id":"https://openalex.org/keywords/mpl-mutation","display_name":"MPL mutation","score":0.7300000190734863},{"id":"https://openalex.org/keywords/laparoscopic-splenectomy","display_name":"laparoscopic splenectomy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.39399999380111694},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9030454158782959},{"id":"https://openalex.org/C2776309230","wikidata":"https://www.wikidata.org/wiki/Q580383","display_name":"Splenectomy","level":3,"score":0.8292447328567505},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.818343997001648},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.7530977725982666},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4832502007484436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45527949929237366},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3274380564689636},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.21297535300254822},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.18297046422958374}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-199246","doi":"https://doi.org/10.1182/blood-2024-199246","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-199246","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.550000011920929,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2115351357","https://openalex.org/W2970811723","https://openalex.org/W2939368495","https://openalex.org/W2523006309","https://openalex.org/W4403361987","https://openalex.org/W1987159900","https://openalex.org/W1883475886","https://openalex.org/W1880500951","https://openalex.org/W4296533651","https://openalex.org/W3194195834"],"abstract_inverted_index":{"Background:":[0],"Treatment":[1,55],"of":[2,24,44,47,60,112,121,157,201,299,323,351,355,384,429,442,496,520,572,578,604],"symptomatic":[3,341],"splenomegaly":[4,62],"in":[5,22,192,199,210,214,281,293,349,381,389,402,459,601],"myelofibrosis":[6],"(MF)":[7],"was":[8,128,190,197,206,223,291,316,362,450],"revolutionized":[9],"by":[10,117],"JAK2":[11,178],"inhibitors":[12],"(JAKi),":[13],"with":[14,40,81,170,231,244,340,344,515,530,570,596],"ruxolitinib":[15,249],"inducing":[16],"a":[17,41,425,440],">35%":[18],"spleen":[19,45,358],"volume":[20],"reduction":[21],"42%":[23],"patients":[25,86,159,262,283,295,332,406,461,475,529,605],"at":[26,439,502],"24":[27],"weeks":[28,512],"(N":[29,50],"Engl":[30,51],"J":[31,52],"Med":[32],"2012;366).":[33],"However,":[34,591],"the":[35,58,74,82,97,104,497,592,602,608],"benefit":[36],"is":[37,568,594],"often":[38],"transient":[39],"median":[42,357,426,441,516],"duration":[43,519],"response":[46,518],"three":[48,245,269],"years":[49,225,286,318,329,431,444,452,522],"Med.":[53],"2011;365).":[54],"modalities":[56],"for":[57,143,336,585,610],"management":[59],"MF-associated":[61],"resistant":[63],"to":[64,103,220,238,274,308,314,326,588,614],"JAKi":[65,113,221,241,247,259,324],"treatment":[66,277,621],"includes":[67],"surgical":[68,398],"resection":[69],"and":[70,124,184,194,212,242,257,270,320,347,366,400,411,421,456,488,504,582,606,618],"involved-field":[71],"radiotherapy.":[72],"In":[73,524],"current":[75],"study,":[76],"we":[77],"describe":[78],"our":[79],"experience":[80],"former.":[83],"Methods:":[84],"Study":[85],"were":[87,141,168,229,368,379,437,492],"retrospectively":[88],"recruited":[89],"from":[90,218,312,321,485],"Mayo":[91],"Clinic":[92],"(USA)":[93],"databases":[94],"based":[95],"on":[96,296,360],"following":[98,563],"criteria:":[99],"i)":[100],"diagnosis":[101,219,313],"according":[102],"International":[105],"Consensus":[106],"Classification":[107],"(Blood":[108],"2022;140:1200);":[109],"ii)":[110],"documentation":[111],"therapy":[114,325],"exposure":[115],"followed":[116],"splenectomy;":[118,300],"iii)":[119],"availability":[120],"information":[122],"before":[123],"after":[125],"splenectomy.":[126,275,309],"Splenectomy":[127,562],"performed":[129,172,292],"as":[130],"an":[131],"open":[132],"(n=29)":[133],"or":[134,565],"laparoscopic":[135],"(n=5)":[136],"surgery.":[137],"Conventional":[138],"statistical":[139],"methods":[140],"employed":[142],"data":[144],"analysis":[145],"(JMP":[146],"Pro":[147],"17.0.0,":[148],"SAS":[149],"Institute,":[150],"Cary,":[151],"NC,":[152],"USA).":[153],"Results:":[154],"A":[155],"total":[156],"34":[158],"(median":[160,284,462],"age":[161],"62.5":[162],"years,":[163],"range":[164],"43-79;":[165],"59%":[166],"males)":[167],"identified":[169],"splenectomies":[171],"between":[173],"2011-2024.":[174],"Mutation":[175],"distribution":[176],"included":[177,248,278,415],"62%,":[179],"CALR":[180],"26%,":[181],"MPL":[182],"3%,":[183],"triple":[185],"negative":[186],"9%.":[187],"ASXL1":[188],"mutation":[189,196],"present":[191,198],"37%":[193],"SRSF2":[195],"26%":[200],"19":[202],"informative":[203],"cases.":[204],"Karyotype":[205],"very":[207],"high":[208],"risk":[209],"15%":[211],"unfavorable":[213],"12%.":[215],"Median":[216,310,447],"time":[217,354],"initiation":[222,322],"7.5":[224],"(0-31).":[226],"Majority":[227],"(76%)":[228],"treated":[230],"one":[232,301],"JAKi;":[233],"18%":[234,348],"had":[235,303,333,499,542],"been":[236],"exposed":[237],"2":[239,484],"different":[240],"6%":[243],"JAKi.":[246],"(n=27),":[250],"momelotinib":[251],"(n=5),":[252,417],"pacritinib":[253],"(n=3),":[254,256,420],"fedratinib":[255],"BMS-911543":[258],"(n=5).":[260],"Two":[261],"underwent":[263],"allogeneic":[264],"stem":[265],"cell":[266,370],"transplant":[267],"(ASCT)":[268],"six":[271],"months":[272,306,559],"prior":[273,307],"Prior":[276],"splenic":[279,289],"radiation":[280],"4":[282,294,540],"0.6":[285],"(0.2-1.2)).":[287],"Pre-operative":[288],"embolization":[290,304],"same":[297],"day":[298],"patient":[302],"10":[305],"interval":[311],"splenectomy":[315,327,337,503],"10.3":[317],"(1.0-35.4)":[319],"1.8":[328],"(0.03-12.1).":[330],"Most":[331],"multiple":[334],"indications":[335],"including":[338],"76%":[339],"splenomegaly,":[342],"50%":[343],"significant":[345,597],"cytopenia,":[346],"preparation":[350],"ASCT.":[352],"At":[353,424],"splenectomy,":[356],"size":[359],"imaging":[361],"25.1":[363],"cm":[364],"(14.7-36)":[365],"55%":[367],"red":[369],"transfusion-dependent":[371,500,573],"(Revised":[372],"international":[373],"working":[374],"group":[375],"criteria).":[376],"Postoperative":[377],"complications":[378,414,599],"reported":[380],"22":[382,498],"(65%)":[383],"patients.":[385],"Major":[386],"bleeding":[387,410],"occurred":[388],"11":[390],"(32%)":[391],"(of":[392],"which":[393],"7":[394],"(64%)":[395],"required":[396],"repeat":[397],"exploration)":[399],"thrombosis":[401],"9":[403],"(26%);":[404],"5":[405,527],"experienced":[407],"both":[408],"major":[409],"thrombosis.":[412],"Other":[413],"infection":[416],"renal":[418],"injury":[419],"pneumothorax":[422],"(n=2).":[423],"follow":[427],"up":[428],"1.7":[430],"(0.01-10.2)":[432],"post-splenectomy,":[433],"12":[434,480],"(35%)":[435],"ASCT":[436,478,589],"documented":[438],"2.3":[443],"(1.5-26.4)":[445],"post-procedure.":[446,560],"post-splenectomy":[448,477],"survival":[449,454,469],"4.3":[451],"(5-year":[453],"44%)":[455],"significantly":[457],"longer":[458],"transplanted":[460],"not":[463],"reached":[464],"vs":[465,471],"2.6":[466],"years;":[467],"5-year":[468],"65%":[470],"22%;":[472],"p=0.02).":[473],"Among":[474],"without":[476,513],"(n=22),":[479],"(55%)":[481],"deaths":[482],"(including":[483],"post-operative":[486],"complications)":[487],"3":[489,558],"leukemic":[490],"transformations":[491],"recorded.":[493],"Additionally,":[494],"13":[495],"anemia":[501,574],"subsequently":[505],"6":[506],"(46%)":[507],"became":[508],"transfusion-independent":[509],"(TI)":[510],"(\u226512":[511],"transfusion)":[514],"TI":[517],"2.8":[521],"(0.3-7.1).":[523],"addition,":[525],"among":[526],"non-transplanted":[528],"baseline":[531],"thrombocytopenia":[532,580],"(<":[533],"50":[534],"x":[535,538,547,551,555],"109/L":[536,548],"(16-42":[537],"109/L)),":[539],"(80%)":[541],"platelet":[543],"count":[544],">":[545],"100":[546],"(median;":[549],"170":[550],"109/L,":[552],"range:":[553],"119-279":[554],"109/L)":[556],"within":[557],"Conclusions:":[561],"JAKi-resistant":[564],"intolerant":[566],"MF":[567],"associated":[569,595],"improvement":[571],"(46%":[575],"response),":[576],"resolution":[577],"severe":[579],"(80%),":[581],"may":[583],"allow":[584],"successful":[586],"transition":[587],"(35%).":[590],"procedure":[593],"perioperative":[598],"occurring":[600],"majority":[603],"underscores":[607],"need":[609],"future":[611],"collaborative":[612],"studies":[613],"develop":[615],"selection":[616],"criteria":[617],"evaluate":[619],"alternative":[620],"modalities.":[622]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}